CGL10:Pharmaceutical-grade peptide lyophilized powder, over 99% purity, directly supplied from the factory, can be shipped worldwide,COA quality
TDS 66 Inquiries
1415456-99-3
Pharmaceutical Grade
99%
shenzhen
huilong
100mg/a bottle
Yes
2026-11-16
polypeptide,Retatrutide,Tirzepatide,Semaglutide,Glow,Benzyl Alcohol
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
CertificatesBasic Info-
Product Name:
Cagrilintide
Other Name:Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide
CAS No.:1415456-99-3
Molecular Formula:C194H312N54O59S2
Molecular Weight:0
EC Number:206-141-6
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
polypeptide,Retatrutide,Tirzepatide,Semaglutide,Glow,Benzyl Alcohol
-
Location:
Room 1403, 3/4, Qinglin Building, South of Dongjiang Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
Company Certificates-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
-
Inquiry History66 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cagrilintide
20 MG Sep 30, 2026
Australia
Cagrilintide
20 MG Aug 17, 2026
United Kingdom
Cagrilintide
10 MG Jul 31, 2026
France
Cagrilintide
10 MG May 22, 2026
Australia
Cagrilintide
4 MT Mar 9, 2026
United States
Cagrilintide
15 MG Feb 25, 2026
United States
Cagrilintide
10 PCS Dec 27, 2025
United States
Cagrilintide
2 MT Dec 21, 2025
United States
Cagrilintide
100 MG Oct 28, 2025
United States
cagrilintide
2 MT Aug 8, 2025
Philippines
Retatrutide
5 MG Aug 5, 2025
China
Cagrilintide
100 G May 6, 2025
United States
cagrilintide
5 MG Feb 18, 2025
United States
Cagrilintide
3 MT Feb 7, 2025
United States
Cagrilintide
100 Nov 12, 2024
United States
Cagrillintide Lyophilized powder
100 MG Jul 4, 2024
United States
Cagrillintide Lyophilized powder
1000 MG Apr 20, 2024
United States
Cagrilintide
10 MG Sep 23, 2026
United States
Cagrilintide
25 MG Aug 31, 2026
United States
Cagrlintide
1 MT Jul 31, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Premium BT10 Peptides, Bulk & Sample Orders Accepted, Custom Synthesis Service
Pharmaceutical Grade / 99%
$100-101/UNIT FOB
-
-
-
-
DS5 Research Peptides, 99% High Purity Powder, Factory Direct Supply, Global Delivery
Pharmaceutical Grade / 99%
$30-32/UNIT FOB
-
-
-
-
AA Stable Bulk Supply - Endocrine Research Material Raw Material
Pharmaceutical Grade / 99%
$35-40/UNIT FOB
-
-
-
-
High Purity LC1200 Research Peptide Powder, Bulk Available, Worldwide Shipping
Pharmaceutical Grade / 99%
$60-62/UNIT FOB
-
-
-
-
MT Biochemical Reagent - Sports Nutrition Research Raw Material
Pharmaceutical Grade / 99%
$35-40/UNIT FOB
-
-
-
-
Thymosin alpha 1#
Pharmaceutical Grade / 99%
$7-9/G FOB
-
